Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides And Phenicols, And Pipeline Analysis)
This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs, namely, aminoglycosides, B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides and phenicols. The market for these classes has been extensively analyzed on the basis of the leading drug launch, expiry, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2011 to 2019, considering 2012 as the base year. The report on antibacterial drugs market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019.
Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/antibacterial-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Geographically, the antibacterial drugs market has been categorized into four regions namely, North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market sizes and forecasts for each of these regions has been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global antibacterial drugs market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis and Porter’s five forces analysis for the antibacterial drugs market.
Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/174477
This report includes a chapter on competitive landscape which includes market share analysis of the leading players in the antibacterial drugs market, in terms of percentage share in the year 2012. A list of recommendations has also been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report also comprises a section on pipeline analysis for this market that includes sales forecast for various drugs currently under phase III clinical trials and expected to be launched during the forecast period.
The report also profiles major players of the antibacterial drugs market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. and other significant players.
The global antibacterial drugs market is segmented as follows:
Antibacterial Drugs Market, by Class
• Aminoglycosides
• B-Lactams
• Tetracyclines
• Sulfonamides
• Quinolones/Fluoroquinolones
• Macrolides
• Phenicols
Antibacterial Drugs Market, by Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
Chapter 2 Executive Summary
To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/174477
Chapter 3 Market Overview
3.1 Introduction to Antibacterial Drugs
3.2 Market Trends and Future Outlook
3.2.1 Impact of generics
3.3 Market Drivers
3.3.1 Global increasing prevalence of a large number of infectious diseases
3.3.2 Rising demand for effective and affordable antibacterial drugs from emerging economies
3.3.3 Aging population
3.4 Market Restraints
3.4.1 Weak pipeline of novel antibacterial drugs
3.4.2 Patent expirations
3.4.3 Rising number of generic drugs in various antibacterial drug classes
3.4.4 Increasing number of multi-drug resistant bacterial strains
3.5 Market Opportunities
3.5.1 Product differentiation through technological innovation, use of monoclonal antibodies (mAbs), combination products, new formulations and indications
3.5.2 Product development through partnerships
3.6 Porter’s Five Forces Analysis for the Global Antibacterial Drugs Market
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threat of substitutes
3.6.4 Threat of new entrants
3.6.5 Competitive rivalry
3.7 Market Attractiveness Analysis: Global Antibacterial Drugs Market, by Geography
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs, namely, aminoglycosides, B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides and phenicols. The market for these classes has been extensively analyzed on the basis of the leading drug launch, expiry, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2011 to 2019, considering 2012 as the base year. The report on antibacterial drugs market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019.
Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/antibacterial-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Geographically, the antibacterial drugs market has been categorized into four regions namely, North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market sizes and forecasts for each of these regions has been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global antibacterial drugs market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis and Porter’s five forces analysis for the antibacterial drugs market.
Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/174477
This report includes a chapter on competitive landscape which includes market share analysis of the leading players in the antibacterial drugs market, in terms of percentage share in the year 2012. A list of recommendations has also been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report also comprises a section on pipeline analysis for this market that includes sales forecast for various drugs currently under phase III clinical trials and expected to be launched during the forecast period.
The report also profiles major players of the antibacterial drugs market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. and other significant players.
The global antibacterial drugs market is segmented as follows:
Antibacterial Drugs Market, by Class
• Aminoglycosides
• B-Lactams
• Tetracyclines
• Sulfonamides
• Quinolones/Fluoroquinolones
• Macrolides
• Phenicols
Antibacterial Drugs Market, by Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
Chapter 2 Executive Summary
To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/174477
Chapter 3 Market Overview
3.1 Introduction to Antibacterial Drugs
3.2 Market Trends and Future Outlook
3.2.1 Impact of generics
3.3 Market Drivers
3.3.1 Global increasing prevalence of a large number of infectious diseases
3.3.2 Rising demand for effective and affordable antibacterial drugs from emerging economies
3.3.3 Aging population
3.4 Market Restraints
3.4.1 Weak pipeline of novel antibacterial drugs
3.4.2 Patent expirations
3.4.3 Rising number of generic drugs in various antibacterial drug classes
3.4.4 Increasing number of multi-drug resistant bacterial strains
3.5 Market Opportunities
3.5.1 Product differentiation through technological innovation, use of monoclonal antibodies (mAbs), combination products, new formulations and indications
3.5.2 Product development through partnerships
3.6 Porter’s Five Forces Analysis for the Global Antibacterial Drugs Market
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threat of substitutes
3.6.4 Threat of new entrants
3.6.5 Competitive rivalry
3.7 Market Attractiveness Analysis: Global Antibacterial Drugs Market, by Geography
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
No comments:
Post a Comment